Tag: Dyslipidemia
-
Konjac Glucomannan: Nature’s Polysaccharide Solution for Modern Metabolic Disorders
Konjac glucomannan (KGM), a water-soluble polysaccharide from Amorphophallus konjac, demonstrates remarkable therapeutic potential across multiple health domains. Clinical evidence reveals significant benefits including 23.2% reduction in fasting glucose, 20.7% decrease in LDL cholesterol, and 30% improvement in bowel movement frequency. With FDA GRAS status and extensive safety validation, KGM emerges as a promising adjunctive therapy…
-
Dyslipidemia Unmasked: A Functional Medicine Approach to Identifying and Reversing Its True Root Causes
Dyslipidemia extends far beyond cholesterol, often signaling deeper imbalances like insulin resistance, inflammation, and gut dysbiosis. Advanced biomarkers like ApoB, Lp(a), and hs-CRP uncover these root causes, enabling targeted, lifestyle-based interventions that offer more effective cardiovascular protection than traditional management alone.